Cancer treatment of today in view of the Nobel Prize

por Ullenhag, Gustav
Publicado 2018

Whole-body MRI including diffusion-weighted imaging compared to CT for staging of malignant melanoma

por Mosavi, Firas, Ullenhag, Gustav, Ahlström, Håkan
Publicado 2013

A Phase I Dose-Escalation Study of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer

por Ullenhag, Gustav J., Rossmann, Eva, Liljefors, Maria
Publicado 2015

Gemcitabine reduces MDSCs, tregs and TGFβ-1 while restoring the teff/treg ratio in patients with pancreatic cancer

por Eriksson, Emma, Wenthe, Jessica, Irenaeus, Sandra, Loskog, Angelica, Ullenhag, Gustav
Publicado 2016

Clinical and Immune Effects of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer

por Ullenhag, Gustav J., Mozaffari, Fariba, Broberg, Mats, Mellstedt, Håkan, Liljefors, Maria
Publicado 2017

Tumoral Pyruvate Kinase L/R as a Predictive Marker for the Treatment of Renal Cancer Patients with Sunitinib and Sorafenib

por Niinivirta, Marjut, Enblad, Gunilla, Lindskog, Cecilia, Pontén, Fredrik, Dragomir, Anca, Ullenhag, Gustav J.
Publicado 2019

Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib

por Niinivirta, Marjut, Georganaki, Maria, Enblad, Gunilla, Lindskog, Cecilia, Dimberg, Anna, Ullenhag, Gustav J.
Publicado 2020

Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib

por Niinivirta, Marjut, Enblad, Gunilla, Edqvist, Per-Henrik, Pontén, Fredrik, Dragomir, Anca, Ullenhag, Gustav J.
Publicado 2017

Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients

por Niinivirta, Marjut, Enblad, Gunilla, Edqvist, Per-Henrik, Pontén, Fredrik, Dragomir, Anca, Ullenhag, Gustav J.
Publicado 2017

Improved survival without increased toxicity with influenza vaccination in cancer patients treated with checkpoint inhibitors

por Valachis, Antonios, Rosén, Camilla, Koliadi, Anthoula, Digkas, Evangelos, Gustavsson, Alice, Nearchou, Andreas, Ullenhag, Gustav J
Publicado 2021

Survival after introduction of adjuvant treatment in stage III melanoma: a nationwide registry-based study

por Helgadottir, Hildur, Ny, Lars, Ullenhag, Gustav J, Falkenius, Johan, Mikiver, Rasmus, Olofsson Bagge, Roger, Isaksson, Karolin
Publicado 2023

Socioeconomy as a prognostic factor for location of death in Swedish palliative cancer patients

por Nilsson, Jonas, Holgersson, Georg, Ullenhag, Gustav, Holmgren, Malin, Axelsson, Bertil, Carlsson, Tobias, Bergqvist, Michael, Bergström, Stefan
Publicado 2021

Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models

por Wenthe, Jessica, Eriksson, Emma, Hellström, Ann-Charlotte, Moreno, Rafael, Ullenhag, Gustav, Alemany, Ramon, Lövgren, Tanja, Loskog, Angelica
Publicado 2023

Predicting immune‐related adverse events using a simplified frailty score in cancer patients treated with checkpoint inhibitors: A retrospective cohort study

por Olsson Ladjevardi, Cecilia, Koliadi, Anthoula, Rydén, Viktoria, Inan El‐Naggar, Ali, Digkas, Evangelos, Valachis, Antonios, Ullenhag, Gustav J.
Publicado 2023

Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients

por Schiza, Aglaia, Irenaeus, Sandra, Ortiz-Nieto, Francisco, Loskog, Angelica, Tötterman, Thomas, Sundin, Anders, Ullenhag, Gustav J., Ahlström, Håkan
Publicado 2019

Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma

por Tholander, Bengt, Koliadi, Anthoula, Botling, Johan, Dahlstrand, Hanna, Von Heideman, Anne, Ahlström, Håkan, Öberg, Kjell, Ullenhag, Gustav J.
Publicado 2020

Immune priming using DC- and T cell-targeting gene therapy sensitizes both treated and distant B16 tumors to checkpoint inhibition

por Wenthe, Jessica, Naseri, Sedigheh, Hellström, Ann-Charlotte, Moreno, Rafael, Ullenhag, Gustav, Alemany, Ramon, Lövgren, Tanja, Eriksson, Emma, Loskog, Angelica
Publicado 2022

Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay

por Blokzijl, Andries, Chen, Lei E., Gustafsdottir, Sigrun M., Vuu, Jimmy, Ullenhag, Gustav, Kämpe, Olle, Landegren, Ulf, Kamali-Moghaddam, Masood, Hedstrand, Håkan
Publicado 2016

Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients

por Loskog, Angelica, Maleka, Aglaia, Mangsbo, Sara, Svensson, Emma, Lundberg, Christina, Nilsson, Anders, Krause, Johan, Agnarsdóttir, Margrét, Sundin, Anders, Ahlström, Håkan, Tötterman, Thomas H, Ullenhag, Gustav
Publicado 2016

Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients

por Irenaeus, Sandra, Schiza, Aglaia, Mangsbo, Sara M., Wenthe, Jessica, Eriksson, Emma, Krause, Johan, Sundin, Anders, Ahlström, Håkan, Tötterman, Thomas H., Loskog, Angelica, Ullenhag, Gustav J.
Publicado 2017